1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Apnea Global Clinical Trials Review, H2, 2014

Apnea Global Clinical Trials Review, H2, 2014

  • November 2014
  • -
  • Global Data
  • -
  • 88 pages

Apnea Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, “Apnea Global Clinical Trials Review, H2, 2014" provides data on the Apnea clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Apnea. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Apnea. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Apnea Global Clinical Trials Review, H2, 2014
Table of Contents

Introduction 6
Apnea 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Apnea to Respiratory Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Apnea to Respiratory Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Apnea 25
Subjects Recruited Over a Period of Time 28
Clinical Trials by Sponsor Type 29
Prominent Sponsors 30
Top Companies Participating in Apnea Therapeutics Clinical Trials 31
Prominent Drugs 33
Clinical Trial Profiles 34
Clinical Trial Overview of Top Companies 34
Teva Pharmaceutical Industries Limited 34
Clinical Trial Overview of Teva Pharmaceutical Industries Limited 34
Merck and Co., Inc. 36
Clinical Trial Overview of Merck and Co., Inc. 36
Cortex Pharmaceuticals, Inc. 37
Clinical Trial Overview of Cortex Pharmaceuticals, Inc. 37
Sumitomo Chemical Company, Limited 38
Clinical Trial Overview of Sumitomo Chemical Company, Limited 38
Phillips Respironics International Inc. 39
Clinical Trial Overview of Phillips Respironics International Inc. 39
Galleon Pharmaceuticals 40
Clinical Trial Overview of Galleon Pharmaceuticals 40
Fisher and Paykel Healthcare Corporation Limited 41
Clinical Trial Overview of Fisher and Paykel Healthcare Corporation Limited 41
BIOPROJET SCR 42
Clinical Trial Overview of BIOPROJET SCR 42
Clinical Trial Overview of Top Institutes / Government 43
Brigham and Women's Hospital 43
Clinical Trial Overview of Brigham and Women's Hospital 43
U.S. Department of Veterans Affairs 44
Clinical Trial Overview of U.S. Department of Veterans Affairs 44
Woolcock Institute of Medical Research 45
Clinical Trial Overview of Woolcock Institute of Medical Research 45
University of Chicago 46
Clinical Trial Overview of University of Chicago 46
National Health and Medical Research Council 47
Clinical Trial Overview of National Health and Medical Research Council 47
University of Wisconsin Madison 48
Clinical Trial Overview of University of Wisconsin Madison 48
Associacao Fundo de Incentivo a Psicofarmcologia 49
Clinical Trial Overview of Associacao Fundo de Incentivo a Psicofarmcologia 49
University of Zurich 50
Clinical Trial Overview of University of Zurich 50
Hospital do Servidor Publico Estadual 51
Clinical Trial Overview of Hospital do Servidor Publico Estadual 51
Washington University School of Medicine 52
Clinical Trial Overview of Washington University School of Medicine 52
Five Key Clinical Profiles 53
Appendix 86
Abbreviations 86
Definitions 86
Research Methodology 87
Secondary Research 87
About GlobalData 88
Contact Us 88
Disclaimer 88
Source 88

List of Tables

Apnea Therapeutics, Global, Clinical Trials by Region, 2014* 7
Apnea Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Apnea Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Apnea Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Apnea Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Apnea Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Apnea Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014* 13
Apnea Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 14
Proportion of Apnea to Respiratory Clinical Trials, G7 Countries (%), 2014* 15
Apnea Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Apnea Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Apnea to Respiratory Clinical Trials, E7 Countries (%), 2014* 18
Apnea Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Apnea Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Apnea Therapeutics, Global, Clinical Trials by Phase, 2014* 21
Apnea Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22
Apnea Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Apnea Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Apnea Therapeutics, Global, Suspended Clinical Trials, 2014* 25
Apnea Therapeutics, Global, Withdrawn Clinical Trials, 2014* 26
Apnea Therapeutics, Global, Terminated Clinical Trials, 2014* 27
Apnea Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 28
Apnea Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 29
Apnea Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 30
Apnea Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 32
Apnea Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 33
Apnea Therapeutics Clinical Trials Market, Global, Clinical Trials by Teva Pharmaceutical Industries Limited, 2014* 34
Apnea Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck and Co., Inc., 2014* 36
Apnea Therapeutics Clinical Trials Market, Global, Clinical Trials by Cortex Pharmaceuticals, Inc., 2014* 37
Apnea Therapeutics Clinical Trials Market, Global, Clinical Trials by Sumitomo Chemical Company, Limited, 2014* 38
Apnea Therapeutics Clinical Trials Market, Global, Clinical Trials by Phillips Respironics International Inc., 2014* 39
Apnea Therapeutics Clinical Trials Market, Global, Clinical Trials by Galleon Pharmaceuticals, 2014* 40
Apnea Therapeutics Clinical Trials Market, Global, Clinical Trials by Fisher and Paykel Healthcare Corporation Limited, 2014* 41
Apnea Therapeutics Clinical Trials Market, Global, Clinical Trials by BIOPROJET SCR, 2014* 42
Apnea Therapeutics Clinical Trials Market, Global, Clinical Trials by Brigham and Women's Hospital, 2014* 43
Apnea Therapeutics Clinical Trials Market, Global, Clinical Trials by U.S. Department of Veterans Affairs, 2014* 44
Apnea Therapeutics Clinical Trials Market, Global, Clinical Trials by Woolcock Institute of Medical Research, 2014* 45
Apnea Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Chicago, 2014* 46
Apnea Therapeutics Clinical Trials Market, Global, Clinical Trials by National Health and Medical Research Council, 2014* 47
Apnea Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Wisconsin Madison, 2014* 48
Apnea Therapeutics Clinical Trials Market, Global, Clinical Trials by Associacao Fundo de Incentivo a Psicofarmcologia, 2014* 49
Apnea Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Zurich, 2014* 50
Apnea Therapeutics Clinical Trials Market, Global, Clinical Trials by Hospital do Servidor Publico Estadual, 2014* 51
Apnea Therapeutics Clinical Trials Market, Global, Clinical Trials by Washington University School of Medicine, 2014* 52

List of Figures

Apnea Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Apnea Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Apnea Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Apnea Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Apnea Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Apnea Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Apnea Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2014* 13
Proportion of Apnea to Respiratory Clinical Trials, G7 Countries (%), 2014* 15
Apnea Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Apnea Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Apnea to Respiratory Clinical Trials, E7 Countries (%), 2014* 18
Apnea Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Apnea Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Apnea Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21
Apnea Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
Apnea Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Apnea Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Apnea Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 28
Apnea Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 29
Apnea Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 30
Apnea Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 31
Apnea Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 33
GlobalData Methodology 87

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.